About
Coagulant Therapeutics develops biologic medicines targeting acute bleeding conditions such as postpartum hemorrhage and traumatic brain injury by optimizing recombinant Factor VIIa molecules to enhance hemostatic control safely and effectively.
Explore Coagulant Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.